Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Cell-type specific expression of adrenergic receptors in a mouse model of Autism Spectrum Disorder

EF 2023-24

Résumé
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder that leads to impairments in speech and delays in reaching developmental milestones such as crawling, walking, and learning new motor skills. A common genetic cause is the 16p11.2 microdeletion, which can be modelled in mice to study the mechanisms of the motor learning delay. Recent work from our lab used in vivo two-photon Ca2+ imaging to show increased levels of activity and synchrony in the primary motor cortex excitatory neurons of 16p11.2+/-mice. The learning delay and increased activity were rescued with chemogenetics to elevate the release of the neuromodulator, noradrenaline (NA). This project aims to discern which receptor subtype NA is acting on and if it is preferentially expressed in parvalbumin inhibitory neurons (PV-INs) or excitatory pyramidal neurons (PyrN). To do so, RNAscope will be employed with specialized probes for the detection of three receptor subtypes: ?1a, ?2a, and ?1. This will be done using PV-tdTomato and Emx1-tdTomato reporter mice lines to determine the expression of the receptors in PV-INs and PyrNs, respectively. Preliminary results have also shown that guanfacine, an ?2 agonist, can improve the motor learning deficit in 16p11.2+/-mice. Using this data, in vivo two-photon dual channel Ca2+ imaging will be used to simultaneously image the activity of PV-INs and PyrNs in the presence of guanfacine to determine if it can reverse the elevated activity. This project will work to reveal a novel microcircuit involved in motor learning and how it is dysregulated in ASD. This research will also serve to advance diagnostic and treatment approaches for children with ASD by exploring the use of commercially available drugs to reverse motor learning deficits.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506292
Name
Stewart Amy
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Cell-type specific expression of adrenergic receptors in a mouse model of Autism Spectrum Disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autism Spectrum Disorder; Motor Learning; Neuroscience; Noradrenaline
Abstract
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder that leads to impairments in speech and delays in reaching developmental milestones such as crawling, walking, and learning new motor skills. A common genetic cause is the 16p11.2 microdeletion, which can be modelled in mice to study the mechanisms of the motor learning delay. Recent work from our lab used in vivo two-photon Ca2+ imaging to show increased levels of activity and synchrony in the primary motor cortex excitatory neurons of 16p11.2+/-mice. The learning delay and increased activity were rescued with chemogenetics to elevate the release of the neuromodulator, noradrenaline (NA). This project aims to discern which receptor subtype NA is acting on and if it is preferentially expressed in parvalbumin inhibitory neurons (PV-INs) or excitatory pyramidal neurons (PyrN). To do so, RNAscope will be employed with specialized probes for the detection of three receptor subtypes: ?1a, ?2a, and ?1. This will be done using PV-tdTomato and Emx1-tdTomato reporter mice lines to determine the expression of the receptors in PV-INs and PyrNs, respectively. Preliminary results have also shown that guanfacine, an ?2 agonist, can improve the motor learning deficit in 16p11.2+/-mice. Using this data, in vivo two-photon dual channel Ca2+ imaging will be used to simultaneously image the activity of PV-INs and PyrNs in the presence of guanfacine to determine if it can reverse the elevated activity. This project will work to reveal a novel microcircuit involved in motor learning and how it is dysregulated in ASD. This research will also serve to advance diagnostic and treatment approaches for children with ASD by exploring the use of commercially available drugs to reverse motor learning deficits.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stewart, Amy
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~